رجوع

Safilo Group S.p.A.

جودة البيانات: 100%

ذروة شراء

SAFLY

OTC Healthcare Medical - Instruments & Supplies

KWD 4.00

KWD 0.00 (0.00%)

القيمة السوقية: 1.20B

مُدرج أيضًا باسم SAFLF OTC

نطاق اليوم

KWD 4.00 KWD 4.00

نطاق 52 أسبوعًا

KWD 2.23 KWD 4.00

حجم التداول

300

متوسط 50 يوم / 200 يوم

KWD 4.00 / KWD 3.42

الإغلاق السابق

KWD 4.00

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس	السهم	وسيط القطاع
P/E	25.5	0.2
P/B	3.1	3.0
ROE %	11.7	3.6
Net Margin %	5.0	3.8
Rev Growth 5Y %	-0.7	9.9
D/E	0.3	0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة	تقدير ربحية السهم	تقدير الإيرادات	المحللون
FY2027	KWD 0.00 KWD 0.00 – KWD 0.00	878.32M	0
FY2026	KWD 0.00 KWD 0.00 – KWD 0.00	842.33M	0

Earnings Surprises

Last 8 quarters

Quarter	Est. EPS	Actual EPS	Surprise
2025-11-05	N/A	KWD 0.24	—
2025-02-25	N/A	KWD 0.01	—
2024-08-01	N/A	KWD 0.05	—
2023-12-31	N/A	-KWD 0.04	—
2023-06-30	N/A	-KWD 0.02	—
2022-12-31	N/A	KWD 0.06	—
2022-06-30	N/A	KWD 0.08	—
2021-12-31	N/A	KWD 0.05	—

Dividend History

1 yr streak

Yield

0.00%

Payout Ratio

0.01%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date	Payment Date	Amount	Yield
Oct 29, 2021	Nov 08, 2021	KWD 0.28	13.44%
Dec 21, 2018	Dec 31, 2018	KWD 0.60	39.89%

النقاط الرئيسية

Revenue declined -0.65% annually over 5 years

Earnings grew 111.41% over the past year

ROE of 11.71% — decent returns on equity

Debt/Equity of 0.25 — conservative balance sheet

Generating 78.07M in free cash flow

PEG of 0.02 suggests growth is underpriced

النمو

Revenue Growth (5Y)

-0.65%

Revenue (1Y)-4.90%

Earnings (1Y)111.41%

FCF Growth (3Y)50.43%

الجودة

Return on Equity

11.71%

ROIC9.43%

Net Margin4.99%

Op. Margin6.53%

الأمان

Debt / Equity

0.25

Current Ratio1.71

Interest Coverage7.76

التقييم

P/E Ratio

25.54

Forward P/EN/A

P/B Ratio3.07

EV/EBITDA20.27

Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-4.90%	Revenue Growth (3Y)	-3.99%
Earnings Growth (1Y)	111.41%	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	-0.65%	Earnings Growth (5Y)	22.00%
Profitability
Revenue (TTM)	944.57M	Net Income (TTM)	47.14M
ROE	11.71%	ROA	6.21%
Gross Margin	60.94%	Operating Margin	6.53%
Net Margin	4.99%	Free Cash Flow (TTM)	78.07M
ROIC	9.43%	FCF Growth (3Y)	50.43%
Safety
Debt / Equity	0.25	Current Ratio	1.71
Interest Coverage	7.76
Dividends
Dividend Yield	0.00%	Payout Ratio	0.01%
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	1 yrs
Valuation
P/E Ratio	25.54	Forward P/E	N/A
P/B Ratio	3.07	P/S Ratio	1.27
PEG Ratio	0.02	Forward PEG	N/A
EV/EBITDA	20.27	Fwd EV/EBITDA	10.72
Forward P/S	1.43	Fwd Earnings Yield	N/A
FCF Yield	6.49%
Market Cap	1.20B	Enterprise Value	1.25B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	944.57M	993.22M	1.02B	1.08B	969.58M
Net Income	47.14M	22.30M	-24.65M	54.16M	21.28M
EPS (Diluted)	0.22	0.05	-0.06	0.13	0.07
Gross Profit	575.63M	592.78M	601.74M	597.45M	445.64M
Operating Income	61.65M	39.39M	7.66M	48.46M	26.08M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	758.63M	842.34M	855.46M	960.27M	937.77M
Total Liabilities	355.75M	414.88M	459.68M	521.35M	571.68M
Shareholders' Equity	392.29M	413.07M	379.20M	409.92M	326.74M
Total Debt	98.23M	130.10M	157.60M	191.11M	192.96M
Cash & Equivalents	52.12M	47.42M	74.90M	77.71M	99.00M
Current Assets	448.13M	510.56M	547.67M	596.30M	561.89M
Current Liabilities	262.33M	277.45M	289.08M	312.55M	310.63M